Medication info
HypoGerein 5/160 mg

HypoGerein 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Dark yellow oblong film-coated tablets
Packaging
28 tablets (14 tablets/Alu-Alu X 2), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201308462 · Approved 2013.07.30 · Insurance code 671703840

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the drug at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher); do not administer this drug to patients with severe renal impairment (creatinine clearance below 10mL/min) or to patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.
Child dose
Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the drug at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher); do not administer this drug to patients with severe renal impairment (creatinine clearance below 10mL/min) or to patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.

Child dose

Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergic reactions to this medication or those with certain heart, kidney, or liver diseases, as well as pregnant or nursing women, should not take this medication. Patients with sodium or fluid depletion should correct their condition before taking this medication, and if symptoms of hypotension occur, they should seek appropriate action immediately. Patients with hyperkalemia or those taking other medications that increase potassium levels should have their potassium levels tested frequently. Patients with renal artery stenosis should use this medication cautiously to prevent worsening of kidney function, and caution is warranted for patients who have recently undergone kidney transplantation due to lack of experience. If symptoms of angioedema occur while taking this medication, it should be discontinued immediately and not resumed. Patients with heart failure or post-myocardial infarction should carefully monitor changes in kidney function when taking this medication. This medication may cause dizziness or fatigue when driving or operating machinery, so caution is advised. There may be drug interactions; therefore, it is essential to consult a doctor or pharmacist when taking other medications simultaneously. Pregnant women, women planning to become pregnant, or nursing mothers are advised not to use this medication, as it may pose risks to the fetus during pregnancy. This medication is not recommended for children under 18 years of age. In the event of an overdose, hypotension, dizziness, and in severe cases, shock may occur, requiring immediate medical attention for appropriate treatment. If any adverse reactions occur while taking this medication, it is crucial to inform healthcare professionals immediately, and regular check-ups are important to monitor the body's condition.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, rash, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver enzyme levels, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory reduction, taste disturbance, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory reduction, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to air and moisture, so it should be stored in a sealed container. It is advisable to maintain a storage temperature between 1°C and 30°C at room temperature.

Appearance and packaging

Appearance

Dark yellow oblong film-coated tablets

Package unit

28 tablets (14 tablets/Alu-Alu X 2), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.